BioVie Inc. (BIVI)

BioVie Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Selling, General & Admin	8.79	11.55	9.77	4.64	1.31	1.26
Research & Development	29.35	33.3	17.26	133.19	1.15	1.01
Depreciation & Amortization	0.23	0.23	0.23	0.23	0.23	0.23
Operating Expenses	38.37	45.08	27.25	138.05	2.69	2.5
Operating Income	-38.37	-45.08	-27.25	-138.05	-2.69	-2.5
Interest Expense	-3.56	-4.3	-2.16	-0.56	-4.77	-0
Interest & Investment Income	1.12	0.56	0.04	0.02	0	0
Other Non Operating Income (Expenses)	4.52	-1.44	3.29	8.28	-9.21	-
EBT Excluding Unusual Items	-36.29	-50.26	-26.08	-130.31	-16.68	-2.5
Other Unusual Items	-	-	-	0.06	-	0.05
Pretax Income	-36.29	-50.26	-26.08	-130.25	-16.68	-2.44
Net Income	-36.29	-50.26	-26.08	-130.25	-16.68	-2.44
Preferred Dividends & Other Adjustments	0.89	-	-	53.6	17.1	0.05
Net Income to Common	-37.18	-50.26	-26.08	-183.85	-33.78	-2.49
Shares Outstanding (Basic)	39	32	25	12	5	3
Shares Outstanding (Diluted)	39	32	25	12	5	3
Shares Change (YoY)	31.40%	31.71%	98.84%	151.61%	94.10%	231.51%
EPS (Basic)	-0.95	-1.55	-1.06	-14.82	-6.85	-0.98
EPS (Diluted)	-0.95	-1.55	-1.06	-14.82	-6.85	-0.98
Free Cash Flow	-35.23	-40.25	-18.99	-10.45	-1.63	-2.5
Free Cash Flow Per Share	-0.90	-1.24	-0.77	-0.84	-0.33	-0.99
EBITDA	-38.14	-44.85	-27.02	-137.82	-2.46	-2.27
D&A For EBITDA	0.23	0.23	0.23	0.23	0.23	0.23
EBIT	-38.37	-45.08	-27.25	-138.05	-2.69	-2.5

Source: S&P Capital IQ. Standard template.